- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03565380
Effectiveness of a Community-based Multi-modal Tai Chi Rehabilitation Program for Patients After Total Knee Arthroplasty
March 23, 2022 updated by: The Hong Kong Polytechnic University
Acceptability and Feasibility of a Community-based Strength, Balance and Tai Chi Rehabilitation Program in Improving Physical Function and Balance of Patients After Total Knee Arthroplasty: a Pilot Randomized Controlled Trial
The rate of falls in patients after total knee arthroplasty (TKA) is high and related to lower limb muscle weakness and poor balance control.
However, since routine post-TKA rehabilitation is uncommon, it is paramount to explore alternative strategies to enhance balance and physical functioning in post-TKA patients.
As Tai Chi is a proven strategy for improving balance in older people, the proposed study aims to determine the feasibility and acceptability of a 12-week community-based post-TKA multimodal Tai Chi program and to collect preliminary data with respect to the efficacy of such a program in improving balance and physical functioning in post-TKA patients as compared to usual postoperative care.
Study Overview
Status
Completed
Conditions
Detailed Description
This is a single-blinded 2-arm RCT.
TKA participants will be randomized to either a 12-week community-based rehabilitation program starting at 12 weeks after TKA, or usual post-operative care without outpatient physiotherapy.
A third group of asymptomatic controls will be recruited to provide comparisons at various time points.
All post-TKA participants will undergo five clinical assessments: 1 week before TKA, and at 6, 12, 24 and 52 weeks after TKA.
The untreated asymptomatic controls will be assessed at baseline, and 12 and 52 weeks from baseline
Study Type
Interventional
Enrollment (Actual)
53
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hong Kong, Hong Kong
- The Hong Kong Polytechnic Univeristy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 60 years or above;
- candidates for primary unilateral TKA who are placed on the TKA waiting list for less than 1 month before their surgery;
- living independently in the community
Exclusion Criteria:
- living in assisted living facilities, requiring nursing care, or planning to reside away from the hospital district within 1 year.
- unstable medical conditions,
- fracture of lower limbs,
- malignancy in the last five years,
- lower limb prosthesis/amputation,
- congenital defect that is considered to cause the present complaint,
- systemic inflammatory and autoimmune diseases,
- previous osteotomy,
- neurological diseases (e.g. Parkinson's disease, stroke),
- blindness, revision TKA,
- complications after primary TKA,
- cognitive impairment with a Mini-Mental State Examination score < 19
- prior experience in practicing Tai Chi exercise for at least 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patients with intervention
12-week community-based Tai Chi rehabilitation program starting at 12 weeks after TKA
|
Participants will receive 12 x 90 minute sessions of supervised exercises over 12 weeks.
In addition to usual care, supervised exercise will be held at the Center of Sports Training and Rehabilitation inside the University and each class will be restricted to no more than 8 participants to ensure sufficient personalized attention.
Each training session involves warm-up together with stretching of lower extremity muscles, strengthening exercises of the major lower extremity muscle groups by Theraband, balancing exercise, Tai Chi training, and rest/ cool-down.
All lower-extremity exercises will be performed bilaterally.
Other Names:
|
|
Experimental: Patients without intervention
usual post-operative care
|
No intervention will be provided
|
|
Experimental: Asymptomatic controls
untreated asymptomatic controls
|
No intervention will be provided
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of recruitment and rate of retention
Time Frame: After 52 week post-TKA follow-up
|
The recruitment and attrition rates will be monitored on a monthly basis to determine the presence of any specific trends.
The recruitment rate (all potential participants), retention and attrition rates (all randomized participants) and completion rates (all enrolled participants) will be assessed at the end of study.
Reasons for ineligibility, and/or non-recruitment of eligible patients will be recorded and grouped into categories.
|
After 52 week post-TKA follow-up
|
|
Facilitators and barriers of the intervention
Time Frame: During the intervention and after 52 week post-TKA follow-up
|
Attendance and exercise logbooks will be used to monitor non-adherence.
The instructor will communicate with non-adherent participants to understand the reasons and barriers for non-adherence and to develop appropriate strategies to improve adherence.
Furthermore, to assess the acceptability of the intervention, each participant in the intervention group will be invited to participate in a face-to-face or video call interviews semi-structured interview based on participants' preferences within 1 month after the final follow-up.
|
During the intervention and after 52 week post-TKA follow-up
|
|
Sample size estimation for the future definitive trial
Time Frame: After 52 week post-TKA follow-up
|
Based on the standard deviation (SD) of The Chinese version of the Knee Injury and Osteoarthritis Outcome Scale (the higher the score, the better the performance )so as to inform the sample size calculation for the effectiveness trial.
|
After 52 week post-TKA follow-up
|
|
Self-reported physical function
Time Frame: 1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
The Chinese version of Knee Injury and Osteoarthritis Outcome Scale will be used to document self-reported physical function and to evaluate knee status before/after TKA
|
1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
|
Number of trips/falls
Time Frame: 1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
The number of trips, falls and fall-related injuries in the 12 months before baseline will be documented.
|
1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objective measures of static and dynamic stability
Time Frame: 1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
When wearing the sensors, participants will perform a tandem stance test with eyes open and eyes closed, the TUG and the 6MWT.
|
1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
|
Knee pain
Time Frame: 1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
It will be measured by an 11-point numeric pain rating scale, which ranges from 0 (no pain) to 10 (the worst imaginable pain).
It documents the current, best, and worst pain in the last 24 hours.
It will be used to record the pain intensity of participant's knee and other body parts, if appropriate.
|
1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
|
Depression
Time Frame: 1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
Depressive symptoms will be examined by the short form Chinese version of the Geriatric Depression Scale, which comprises 15 questions.
|
1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
|
Physical activity level
Time Frame: 1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
Physical activity will be assessed by the Physical Activity Scale for the Elderly (Chinese version), which is a 12-item questionnaire that documents leisure, physical, household and work-related activities over the last 7 days.
|
1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
|
Fear of falling
Time Frame: 1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
Concern of falling will be measured with the Falls Efficacy Scale, which showed good reliability and validity in measuring fear of falling in frail older people.
|
1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
|
Global impression of change
Time Frame: 1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
Symptom severity, treatment response and the efficacy of treatment 24-weeks post-TKA will be measured by the Global Impression of change scale.
|
1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
|
Joint range of motion
Time Frame: 1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
The ranges of motion of hip, knee, and ankle joints will be evaluated using a goniometer.
These assessments are chosen because limited knee/ankle joint ranges have been reported as potential risk factors for falls.
|
1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
|
Balance assessment
Time Frame: 1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
The Brief-Balance Evaluation Systems test comprises six static and six dynamic tasks of different difficulty levels.
|
1-week before TKA, 6-, 12-, 24- and 52-week post-TKA follow-ups
|
|
Remote monitoring of physical activity
Time Frame: over 7 days at 1 week before TKA, 7 days during the 12th , 24th and 52th week after
|
Participants' physical activity will be measured by a wearable sensor.
accelerometer.
The participant will wear ActiGraph on the right hip, near the iliac crest for 7 days except during sleeping, showering or bathing.
Data from the vertical axis will be recorded in 15s epochs and be initialized using the normal filter.
The data be classified into different activity levels by ActiLife V6.11.0: sedentary (0-99 counts/minute), light (100-2019 counts/minute), moderate (2020-5998 counts/minute), and vigorous (> 5999 counts/minute).
|
over 7 days at 1 week before TKA, 7 days during the 12th , 24th and 52th week after
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Arnold Wong, PhD, The Hong Kong Polytechnic University, Department of Rehabilitation Sciences
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 11, 2018
Primary Completion (Actual)
June 30, 2021
Study Completion (Actual)
August 30, 2021
Study Registration Dates
First Submitted
May 30, 2018
First Submitted That Met QC Criteria
June 11, 2018
First Posted (Actual)
June 21, 2018
Study Record Updates
Last Update Posted (Actual)
March 25, 2022
Last Update Submitted That Met QC Criteria
March 23, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- HSEARS20171225001AW
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.